blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1793865

EP1793865 - GENE OR DRUG DELIVERY SYSTEM [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  27.05.2016
Database last updated on 24.08.2024
Most recent event   Tooltip27.05.2016Application deemed to be withdrawnpublished on 29.06.2016  [2016/26]
Applicant(s)For all designated states
Baylor Research Institute
3434 Live Oak Street
Dallas, TX 75204 / US
For all designated states
Board of Regents, The University of Texas System
201 West Seventh Street
Austin, TX 78701 / US
[N/P]
Former [2007/24]For all designated states
Baylor Research Institute
3434 Live Oak Street
Dallas, TX 75204 / US
For all designated states
Board of Regents, The University of Texas System
201 West Seventh Street
Austin TX 78701 / US
Inventor(s)01 / GRAYBURN, Paul, A.
2710 Lawtherwood Court
Dallas, Texas 75214 / US
02 / CHEN, Shuyuan
1518 Streams Way
Allen, TX 75002 / US
 [2010/30]
Former [2007/24]01 / GRAYBURN, Paul, A.
1405 Sagewood Drive
DeSoto, TX 75115 / US
02 / CHEN, Shuyuan
1518 Streams Way
Allen, TX 75002 / US
Representative(s)SONN Patentanwälte GmbH & Co KG
Riemergasse 14
1010 Wien / AT
[N/P]
Former [2007/24]Sonn & Partner Patentanwälte
Riemergasse 14
1010 Wien / AT
Application number, filing date05858371.705.08.2005
[2007/24]
WO2005US28083
Priority number, dateUS20040599204P05.08.2004         Original published format: US 599204 P
[2007/24]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2007008220
Date:18.01.2007
Language:EN
[2007/03]
Type: A2 Application without search report 
No.:EP1793865
Date:13.06.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 18.01.2007 takes the place of the publication of the European patent application.
[2007/24]
Search report(s)International search report - published on:US07.02.2008
(Supplementary) European search report - dispatched on:EP14.04.2009
ClassificationIPC:A61B8/00, A61K38/00
[2008/12]
CPC:
A61K9/127 (EP,US); A61K41/0028 (EP,US); A61K48/0075 (EP,US);
A61K9/0019 (EP,US); A61K9/1272 (EP,US); A61K9/1274 (EP,US);
A61P35/00 (EP) (-)
Former IPC [2007/24]A61K48/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/24]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:SYSTEM ZUR GEN- ODER ARZNEIMITTELABGABE[2007/24]
English:GENE OR DRUG DELIVERY SYSTEM[2007/24]
French:SYSTEME DE DISTRIBUTION DE MEDICAMENT OU DE GENE[2007/24]
Entry into regional phase20.02.2007National basic fee paid 
20.02.2007Search fee paid 
20.02.2007Designation fee(s) paid 
20.02.2007Examination fee paid 
Examination procedure20.02.2007Amendment by applicant (claims and/or description)
20.02.2007Examination requested  [2007/24]
27.07.2009Despatch of a communication from the examining division (Time limit: M04)
30.11.2009Reply to a communication from the examining division
19.03.2013Despatch of a communication from the examining division (Time limit: M06)
13.09.2013Reply to a communication from the examining division
06.07.2015Despatch of a communication from the examining division (Time limit: M06)
19.01.2016Application deemed to be withdrawn, date of legal effect  [2016/26]
12.02.2016Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2016/26]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  27.07.2009
Fees paidRenewal fee
13.08.2007Renewal fee patent year 03
28.03.2008Renewal fee patent year 04
14.08.2009Renewal fee patent year 05
31.08.2010Renewal fee patent year 06
05.08.2011Renewal fee patent year 07
09.08.2012Renewal fee patent year 08
19.08.2013Renewal fee patent year 09
13.08.2014Renewal fee patent year 10
Penalty fee
Additional fee for renewal fee
31.08.201511   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XY]WO0191805  (BRACCO RES USA [US], et al) [X] 1-7,9-11,16-22,28,29 * page 28, line 1 - page 51, line 18; claim - * [Y] 1-30;
 [XY]WO03015831  (BRISTOL MYERS SQUIBB PHARMA CO [US]) [X] 1,6,9-11,17-21,29 * page 7, paragraph 1 - page 8, paragraph 5; claim - * [Y] 1-30;
 [XY]  - SEEMANN S ET AL, "Pharmaceutical evaluation of gas-filled microparticles as gene delivery system", PHARMACEUTICAL RESEARCH (NEW YORK), (200203), vol. 19, no. 3, ISSN 0724-8741, pages 250 - 257, XP002521569 [X] 19-21,23,28 * abstract; page 251, left-hand column, paragraph 2; discussion; * [Y] 1-30

DOI:   http://dx.doi.org/10.1023/A:1014430631844
 [PXY]  - KORPANTY G ET AL, "Targeting of VEGF-mediated angiogenesis to rat myocardium using ultrasonic destruction of microbubbles", GENE THERAPY, (20050414), vol. 12, no. 17, ISSN 0969-7128, pages 1305 - 1312, XP002521570 [PX] 1-11,14-23,26-29 * abstract; materials and methods; * [PY] 1-30

DOI:   http://dx.doi.org/10.1038/sj.gt.3302532
 [Y]  - EPSTEIN P N ET AL, "Expression of yeast hexokinase in pancreatic beta cells of transgenic mice reduces blood glucose, enhances insulin secretion, and decreases diabetes", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (1992), vol. 89, no. 24, ISSN 0027-8424, pages 12038 - 12042, XP002521610 [Y] 8,12,13,23-25 * abstract; materials and methods; *

DOI:   http://dx.doi.org/10.1073/pnas.89.24.12038
 [Y]  - ISHIHARA H ET AL, "Overexpression of Hexokinase I but not GLUT1 Glucose Transporter Alters Concentration Dependence of Glucose-stimulated Insulin Secretion in Pancreatic beta-Cell Line MIN6", JOURNAL OF BIOLOGICAL CHEMISTRY, (1994), vol. 269, no. 4, ISSN 0021-9258, pages 3081 - 3087, XP002521611 [Y] 8,12,13,23-25 * abstract; experimental procedures; *
 [T]  - CHEN S ET AL, "Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (200605), vol. 103, no. 22, ISSN 0027-8424, pages 8469 - 8474, XP002521571 [T] 1-30 * the whole document *

DOI:   http://dx.doi.org/10.1073/PNAS.0602921103
International search[X]US5580575  (UNGER EVAN C [US], et al);
 [Y]US6486380  (EPSTEIN PAUL N [US]);
 [Y]US6521211  (UNGER EVAN C [US], et al);
 [Y]US2004086485  (AGUILAR-CORDOVA CARLOS ESTUARD [US])
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.